Is 3M’s Resurgence Signaling a Sustainable Recovery?

The industrial conglomerate 3M is demonstrating unexpected strength following years of transformation, with surprisingly robust quarterly earnings and an upgraded annual forecast suggesting its turnaround strategy is gaining traction. The former problem child of the industrial sector now faces the critical question: can this legacy giant genuinely secure a lasting return to growth?

Strategic Shifts Yield Operational Gains

Behind 3M’s recovery lies a profound corporate transformation. The spin-off of its healthcare business, Solventum, in April 2024 created a leaner, more focused industrial entity. Concurrently, the company is systematically working toward complete PFAS chemical phase-out by the end of 2025—a necessary adaptation to evolving regulatory landscapes.

The third quarter of 2025 delivered the anticipated turnaround for 3M. Adjusted earnings reached $2.19 per share, representing a 10 percent year-over-year increase. More significantly, revenue climbed to $6.52 billion, while organic growth of 3.2 percent marked the fourth consecutive quarter of positive performance. This consistent recovery has surprised numerous market observers who had previously written off the manufacturing giant.

Wall Street Responds with Upgraded Assessments

This positive trajectory hasn’t gone unnoticed by financial institutions. UBS reaffirmed its “Buy” recommendation while raising its price target to $190, citing accelerated organic growth. Even more notably, Morgan Stanley upgraded 3M from “Underweight” to “Equalweight,” establishing a $160 price objective. These moves indicate a clear reassessment of the company’s prospects within the investment community.

Should investors sell immediately? Or is it worth buying 3M?

Management confidence is reflected in their revised full-year 2025 guidance, now projecting $7.95 to $8.05 per share. This upward adjustment strongly signals that operational improvements are bearing fruit and cash flow generation is stabilizing.

Innovation Pipeline and Market Positioning

Parallel to its restructuring efforts, 3M continues to prioritize innovation. The company introduced 70 new products during the third quarter alone, bringing its yearly total to 196 new developments since January. These figures underscore the company’s growth ambitions and commitment to refreshing its product portfolio.

At the China International Import Expo, 3M showcased environmentally focused future technologies—a strategically astute move within one of the world’s most crucial growth markets. This positioning demonstrates the company’s awareness of evolving global priorities and its adaptation to new market demands.

With an almost unbroken dividend payment record spanning over a century, 3M offers investors stability during uncertain economic periods. The upcoming dividend distribution on December 12 will serve as the next test of the company’s recovery momentum. The continued progression of 3M’s transformation will ultimately determine whether current optimism reflects sustainable strength or merely temporary improvement.